首页 > 最新文献

Radiology. Imaging cancer最新文献

英文 中文
Current Status of Cancer Genomics and Imaging Phenotypes: What Radiologists Need to Know. 癌症基因组学和成像表型的现状:放射学家需要知道的。
IF 4.4 Q1 ONCOLOGY Pub Date : 2023-11-01 DOI: 10.1148/rycan.220153
Eva Mendes Serrão, Maximiliano Klug, Brian M Moloney, Aaditeya Jhaveri, Roberto Lo Gullo, Katja Pinker, Gary Luker, Masoom A Haider, Atul B Shinagare, Xiaoyang Liu

Ongoing discoveries in cancer genomics and epigenomics have revolutionized clinical oncology and precision health care. This knowledge provides unprecedented insights into tumor biology and heterogeneity within a single tumor, among primary and metastatic lesions, and among patients with the same histologic type of cancer. Large-scale genomic sequencing studies also sparked the development of new tumor classifications, biomarkers, and targeted therapies. Because of the central role of imaging in cancer diagnosis and therapy, radiologists need to be familiar with the basic concepts of genomics, which are now becoming the new norm in oncologic clinical practice. By incorporating these concepts into clinical practice, radiologists can make their imaging interpretations more meaningful and specific, facilitate multidisciplinary clinical dialogue and interventions, and provide better patient-centric care. This review article highlights basic concepts of genomics and epigenomics, reviews the most common genetic alterations in cancer, and discusses the implications of these concepts on imaging by organ system in a case-based manner. This information will help stimulate new innovations in imaging research, accelerate the development and validation of new imaging biomarkers, and motivate efforts to bring new molecular and functional imaging methods to clinical radiology. Keywords: Oncology, Cancer Genomics, Epignomics, Radiogenomics, Imaging Markers Supplemental material is available for this article. © RSNA, 2023.

癌症基因组学和表观基因组学的不断发现彻底改变了临床肿瘤学和精准医疗。这一知识为单个肿瘤、原发性和转移性病灶以及同一组织学类型癌症患者的肿瘤生物学和异质性提供了前所未有的见解。大规模的基因组测序研究也引发了新的肿瘤分类、生物标志物和靶向疗法的发展。由于影像学在癌症诊断和治疗中的核心作用,放射科医生需要熟悉基因组学的基本概念,这正成为肿瘤临床实践的新规范。通过将这些概念融入临床实践,放射科医生可以使他们的成像解释更有意义和具体性,促进多学科临床对话和干预,并提供更好的以患者为中心的护理。这篇综述文章强调了基因组学和表观基因组学的基本概念,回顾了癌症最常见的基因改变,并以基于病例的方式讨论了这些概念对器官系统成像的影响。这些信息将有助于刺激成像研究的新创新,加速新的成像生物标志物的开发和验证,并推动将新的分子和功能成像方法引入临床放射学。关键词:肿瘤学,癌症基因组学,表观遗传学,放射基因组学,成像标记物补充材料可用于本文。©RSNA,2023年。
{"title":"Current Status of Cancer Genomics and Imaging Phenotypes: What Radiologists Need to Know.","authors":"Eva Mendes Serrão, Maximiliano Klug, Brian M Moloney, Aaditeya Jhaveri, Roberto Lo Gullo, Katja Pinker, Gary Luker, Masoom A Haider, Atul B Shinagare, Xiaoyang Liu","doi":"10.1148/rycan.220153","DOIUrl":"10.1148/rycan.220153","url":null,"abstract":"<p><p>Ongoing discoveries in cancer genomics and epigenomics have revolutionized clinical oncology and precision health care. This knowledge provides unprecedented insights into tumor biology and heterogeneity within a single tumor, among primary and metastatic lesions, and among patients with the same histologic type of cancer. Large-scale genomic sequencing studies also sparked the development of new tumor classifications, biomarkers, and targeted therapies. Because of the central role of imaging in cancer diagnosis and therapy, radiologists need to be familiar with the basic concepts of genomics, which are now becoming the new norm in oncologic clinical practice. By incorporating these concepts into clinical practice, radiologists can make their imaging interpretations more meaningful and specific, facilitate multidisciplinary clinical dialogue and interventions, and provide better patient-centric care. This review article highlights basic concepts of genomics and epigenomics, reviews the most common genetic alterations in cancer, and discusses the implications of these concepts on imaging by organ system in a case-based manner. This information will help stimulate new innovations in imaging research, accelerate the development and validation of new imaging biomarkers, and motivate efforts to bring new molecular and functional imaging methods to clinical radiology. <b>Keywords:</b> Oncology, Cancer Genomics, Epignomics, Radiogenomics, Imaging Markers <i>Supplemental material is available for this article.</i> © RSNA, 2023.</p>","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"5 6","pages":"e220153"},"PeriodicalIF":4.4,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10698595/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71426351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Noninferiority in Overall Survival with Thermal Ablation for Treating Small Colorectal Liver Metastases. 热消融治疗小肠癌肝转移总生存率的非劣效性。
IF 4.4 Q1 ONCOLOGY Pub Date : 2023-11-01 DOI: 10.1148/rycan.239020
Yuan-Mao Lin
{"title":"Noninferiority in Overall Survival with Thermal Ablation for Treating Small Colorectal Liver Metastases.","authors":"Yuan-Mao Lin","doi":"10.1148/rycan.239020","DOIUrl":"10.1148/rycan.239020","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"5 6","pages":"e239020"},"PeriodicalIF":4.4,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10698611/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71426352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MR Fingerprinting for Contrast Agent-free and Quantitative Characterization of Focal Liver Lesions. 无造影剂和定量表征局灶性肝脏病变的MR指纹图谱。
IF 4.4 Q1 ONCOLOGY Pub Date : 2023-11-01 DOI: 10.1148/rycan.230036
Shohei Fujita, Katsuhiro Sano, Gastao Cruz, Carlos Velasco, Hideo Kawasaki, Yuki Fukumura, Masami Yoneyama, Akiyoshi Suzuki, Kotaro Yamamoto, Yuichi Morita, Takashi Arai, Issei Fukunaga, Wataru Uchida, Koji Kamagata, Osamu Abe, Ryohei Kuwatsuru, Akio Saiura, Kenichi Ikejima, René Botnar, Claudia Prieto, Shigeki Aoki

Purpose To evaluate the feasibility of liver MR fingerprinting (MRF) for quantitative characterization and diagnosis of focal liver lesions. Materials and Methods This single-site, prospective study included 89 participants (mean age, 62 years ± 15 [SD]; 45 women, 44 men) with various focal liver lesions who underwent MRI between October 2021 and August 2022. The participants underwent routine clinical MRI, non-contrast-enhanced liver MRF, and reference quantitative MRI with a 1.5-T MRI scanner. The bias and repeatability of the MRF measurements were assessed using linear regression, Bland-Altman plots, and coefficients of variation. The diagnostic capability of MRF-derived T1, T2, T2*, proton density fat fraction (PDFF), and a combination of these metrics to distinguish benign from malignant lesions was analyzed according to the area under the receiver operating characteristic curve (AUC). Results Liver MRF measurements showed moderate to high agreement with reference measurements (intraclass correlation = 0.94, 0.77, 0.45, and 0.61 for T1, T2, T2*, and PDFF, respectively), with underestimation of T2 values (mean bias in lesion = -0.5%, -29%, 5.8%, and -8.2% for T1, T2, T2*, and PDFF, respectively). The median coefficients of variation for repeatability of T1, T2, and T2* values were 2.5% (IQR, 3.6%), 3.1% (IQR, 5.6%), and 6.6% (IQR, 13.9%), respectively. After considering multicollinearity, a combination of MRF measurements showed a high diagnostic performance in differentiating benign from malignant lesions (AUC = 0.92 [95% CI: 0.86, 0.98]). Conclusion Liver MRF enabled the quantitative characterization of various focal liver lesions in a single breath-hold acquisition. Keywords: MR Imaging, Abdomen/GI, Liver, Imaging Sequences, Technical Aspects, Tissue Characterization, Technology Assessment, Diagnosis, Liver Lesions, MR Fingerprinting, Quantitative Characterization Supplemental material is available for this article. © RSNA, 2023.

目的探讨肝脏MR指纹识别(MRF)在肝局灶性病变定量诊断中的可行性。材料与方法本研究纳入89名参与者(平均年龄62岁±15岁[SD];45名女性,44名男性)在2021年10月至2022年8月期间接受了MRI检查。参与者接受常规临床MRI,非对比增强肝脏MRI和参考定量MRI与1.5 t MRI扫描仪。使用线性回归、Bland-Altman图和变异系数评估MRF测量的偏倚和可重复性。根据受者工作特征曲线下面积(AUC)分析mrf衍生的T1、T2、T2*、质子密度脂肪分数(PDFF)以及这些指标的组合对良恶性病变的诊断能力。结果肝脏MRF测量值与参考测量值具有中等至高度的一致性(T1、T2、T2*和PDFF的类内相关性分别为0.94、0.77、0.45和0.61),T2值被低估(T1、T2、T2*和PDFF的病变平均偏差分别为-0.5%、-29%、5.8%和-8.2%)。T1、T2和T2*值的重复性变异系数中位数分别为2.5% (IQR, 3.6%)、3.1% (IQR, 5.6%)和6.6% (IQR, 13.9%)。考虑多重共线性后,MRF测量组合在区分良恶性病变方面显示出很高的诊断性能(AUC = 0.92 [95% CI: 0.86, 0.98])。结论肝脏磁共振成像能够在单次屏气采集中定量表征各种局灶性肝脏病变。关键词:磁共振成像,腹部/胃肠道,肝脏,成像序列,技术方面,组织表征,技术评估,诊断,肝脏病变,磁共振指纹,定量表征本文有补充材料。©rsna, 2023。
{"title":"MR Fingerprinting for Contrast Agent-free and Quantitative Characterization of Focal Liver Lesions.","authors":"Shohei Fujita, Katsuhiro Sano, Gastao Cruz, Carlos Velasco, Hideo Kawasaki, Yuki Fukumura, Masami Yoneyama, Akiyoshi Suzuki, Kotaro Yamamoto, Yuichi Morita, Takashi Arai, Issei Fukunaga, Wataru Uchida, Koji Kamagata, Osamu Abe, Ryohei Kuwatsuru, Akio Saiura, Kenichi Ikejima, René Botnar, Claudia Prieto, Shigeki Aoki","doi":"10.1148/rycan.230036","DOIUrl":"10.1148/rycan.230036","url":null,"abstract":"<p><p>Purpose To evaluate the feasibility of liver MR fingerprinting (MRF) for quantitative characterization and diagnosis of focal liver lesions. Materials and Methods This single-site, prospective study included 89 participants (mean age, 62 years ± 15 [SD]; 45 women, 44 men) with various focal liver lesions who underwent MRI between October 2021 and August 2022. The participants underwent routine clinical MRI, non-contrast-enhanced liver MRF, and reference quantitative MRI with a 1.5-T MRI scanner. The bias and repeatability of the MRF measurements were assessed using linear regression, Bland-Altman plots, and coefficients of variation. The diagnostic capability of MRF-derived T1, T2, T2*, proton density fat fraction (PDFF), and a combination of these metrics to distinguish benign from malignant lesions was analyzed according to the area under the receiver operating characteristic curve (AUC). Results Liver MRF measurements showed moderate to high agreement with reference measurements (intraclass correlation = 0.94, 0.77, 0.45, and 0.61 for T1, T2, T2*, and PDFF, respectively), with underestimation of T2 values (mean bias in lesion = -0.5%, -29%, 5.8%, and -8.2% for T1, T2, T2*, and PDFF, respectively). The median coefficients of variation for repeatability of T1, T2, and T2* values were 2.5% (IQR, 3.6%), 3.1% (IQR, 5.6%), and 6.6% (IQR, 13.9%), respectively. After considering multicollinearity, a combination of MRF measurements showed a high diagnostic performance in differentiating benign from malignant lesions (AUC = 0.92 [95% CI: 0.86, 0.98]). Conclusion Liver MRF enabled the quantitative characterization of various focal liver lesions in a single breath-hold acquisition. <b>Keywords:</b> MR Imaging, Abdomen/GI, Liver, Imaging Sequences, Technical Aspects, Tissue Characterization, Technology Assessment, Diagnosis, Liver Lesions, MR Fingerprinting, Quantitative Characterization <i>Supplemental material is available for this article.</i> © RSNA, 2023.</p>","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"5 6","pages":"e230036"},"PeriodicalIF":4.4,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10698593/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138299766","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alternate CMS Payment Structure for Outpatient Services: A Road to Improving Access to Molecular Imaging in Oncologic Care. 门诊服务的替代CMS支付结构:改善肿瘤护理中分子成像的途径。
IF 4.4 Q1 ONCOLOGY Pub Date : 2023-11-01 DOI: 10.1148/rycan.230166
Kritika Subramanian, Jana Ivanidze, Manny Paris, Andres Ricaurte Fajardo, Joseph R Osborne
{"title":"Alternate CMS Payment Structure for Outpatient Services: A Road to Improving Access to Molecular Imaging in Oncologic Care.","authors":"Kritika Subramanian, Jana Ivanidze, Manny Paris, Andres Ricaurte Fajardo, Joseph R Osborne","doi":"10.1148/rycan.230166","DOIUrl":"10.1148/rycan.230166","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"5 6","pages":"e230166"},"PeriodicalIF":4.4,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10701460/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"72015226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
PARP-targeted Meitner-Auger Electron-emitting Radiopharmaceutical for Radioligand Therapy. 用于放射配体治疗的parp靶向迈特纳-俄歇电子发射放射性药物。
IF 4.4 Q1 ONCOLOGY Pub Date : 2023-11-01 DOI: 10.1148/rycan.239022
Kel Vin Tan
{"title":"PARP-targeted Meitner-Auger Electron-emitting Radiopharmaceutical for Radioligand Therapy.","authors":"Kel Vin Tan","doi":"10.1148/rycan.239022","DOIUrl":"10.1148/rycan.239022","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"5 6","pages":"e239022"},"PeriodicalIF":4.4,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10698612/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136398961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Taking Time to Recognize Caregivers. 花时间认识照顾者。
IF 4.4 Q1 ONCOLOGY Pub Date : 2023-11-01 DOI: 10.1148/rycan.230191
Gary D Luker
{"title":"Taking Time to Recognize Caregivers.","authors":"Gary D Luker","doi":"10.1148/rycan.230191","DOIUrl":"10.1148/rycan.230191","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"5 6","pages":"e230191"},"PeriodicalIF":4.4,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10698583/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138299767","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Addressing Follow-up of Enhancing Lesions at Contrast-enhanced Mammography without Correlate of Other Imaging Modalities. 在没有其他成像方式相关的情况下,解决造影增强病变的随访问题。
IF 4.4 Q1 ONCOLOGY Pub Date : 2023-11-01 DOI: 10.1148/rycan.239021
Lauren E Burkard-Mandel
{"title":"Addressing Follow-up of Enhancing Lesions at Contrast-enhanced Mammography without Correlate of Other Imaging Modalities.","authors":"Lauren E Burkard-Mandel","doi":"10.1148/rycan.239021","DOIUrl":"10.1148/rycan.239021","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"5 6","pages":"e239021"},"PeriodicalIF":4.4,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10698596/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138299765","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mentorship in Radiology Research: A Guide for Mentors and Mentees. 放射学研究中的指导:导师和学员指南。
IF 4.4 Q1 ONCOLOGY Pub Date : 2023-11-01 DOI: 10.1148/rycan.230176
Mohamed M Soliman, Tae-Hyung Kim, Monica Cheng, Anna Sophia McKenney, Mohammad-Kasim Fassia, Nicole A Lamparello, Jeong Min Lee, Hebert A Vargas, Sungmin Woo
{"title":"Mentorship in Radiology Research: A Guide for Mentors and Mentees.","authors":"Mohamed M Soliman, Tae-Hyung Kim, Monica Cheng, Anna Sophia McKenney, Mohammad-Kasim Fassia, Nicole A Lamparello, Jeong Min Lee, Hebert A Vargas, Sungmin Woo","doi":"10.1148/rycan.230176","DOIUrl":"10.1148/rycan.230176","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"5 6","pages":"e230176"},"PeriodicalIF":4.4,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10698589/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136398960","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New Suspicious Findings at Breast MRI after Neoadjuvant Therapy. 新辅助治疗后乳腺MRI的新可疑发现。
IF 5.6 Q1 ONCOLOGY Pub Date : 2023-11-01 DOI: 10.1148/rycan.239018
Amy Chang, Jessica Hayward
{"title":"New Suspicious Findings at Breast MRI after Neoadjuvant Therapy.","authors":"Amy Chang, Jessica Hayward","doi":"10.1148/rycan.239018","DOIUrl":"10.1148/rycan.239018","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"5 6","pages":"e239018"},"PeriodicalIF":5.6,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10698588/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"54230774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Improved Visualization of Lymphomatous Cardiac Involvement with Retrospective PET/MRI Fusion. 回顾性PET/MRI融合技术改善心脏淋巴瘤的可视化。
IF 4.4 Q1 ONCOLOGY Pub Date : 2023-11-01 DOI: 10.1148/rycan.230073
Joshua G Hunter, Mohamed Gad, Amit Gupta
{"title":"Improved Visualization of Lymphomatous Cardiac Involvement with Retrospective PET/MRI Fusion.","authors":"Joshua G Hunter, Mohamed Gad, Amit Gupta","doi":"10.1148/rycan.230073","DOIUrl":"10.1148/rycan.230073","url":null,"abstract":"","PeriodicalId":20786,"journal":{"name":"Radiology. Imaging cancer","volume":"5 6","pages":"e230073"},"PeriodicalIF":4.4,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10701461/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41210720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Radiology. Imaging cancer
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1